Sign in

CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company

Serina Therapeutics, Inc.

Sign in to watch
Ticker
SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
AL
Entity type
operating
EIN
821436829
Phone
(256) 327-9630
Business address
601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
Former names
AgeX Therapeutics, Inc.
  1. 4 Planned sale Chief Scientific Officer sold 6,500 shares at $4.10 ($26,650)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale Chief Scientific Officer sold 3,398 shares at $4.24 ($14,408)
  8. 4 Planned sale Chief Scientific Officer sold 3,102 shares at $4.40 ($13,634)
  9. 4 Planned sale Chief Scientific Officer sold 5,551 shares at $4.96 ($27,541)
  10. 4 Planned sale Chief Scientific Officer sold 949 shares at $5.19 ($4,921)
  11. 4 Planned sale Chief Scientific Officer sold 6,500 shares at $4.97 ($32,287)
  12. 4 Planned sale Chief Scientific Officer sold 4,326 shares at $5.20 ($22,495)
  13. 4 Planned sale Chief Scientific Officer sold 47,674 shares at an average $6.95 ($331,418)
  14. 4 Planned sale Chief Scientific Officer sold 4,304 shares at an average $5.18 ($22,284)
  15. 4 Planned sale Chief Scientific Officer sold 5,500 shares at $5.25 ($28,875)
  16. 4 Planned sale Chief Scientific Officer sold 5,500 shares at $5.17 ($28,435)
  17. 4 Planned sale Chief Scientific Officer sold 4,196 shares at $6.50 ($27,274)
  18. 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.89 ($38,285)
  19. 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.34 ($34,710)
  20. 4 Open-market sale Chief Scientific Officer sold 6,500 shares at $5.01 ($32,565)

Page 3 of 9 · 177 filings